English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Tools annual

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Presents the access of premium content as premium feature

Premium Content

Global: Zendy Plus annual

Global: Zendy Free Plan

Steven J. Wolf1,3, Laurence P.G. Wakelin2 and Daniel R. Catchpoole1,3 1The Biospecimens Research Group and Tumour Bank, Children’s Cancer Research Unit, The Kids Research Institute, The Children’s Hospital at Westmead, Westmead, NSW, 2The School of Medical Science, The Faculty of Medicine, The University of New South Wales, Sydney, NSW, 3Faculty of Medicine, The University of Sydney, NSW, Australia

Considerations for Treatment Development in Rhabdomyosarcoma: In Vitro Assessment of Novel DNA Binding Drugs